Leap Therapeutics Stock (NASDAQ: LPTX) stock price, news, charts, stock research, profile.
Open | $2.17 |
Close | $2.11 |
Volume / Avg. | 65.28K / 164.51K |
Day Range | 2.09 - 2.20 |
52 Wk Range | 1.24 - 5.00 |
Market Cap | $85.71M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 3.29% |
Days to Cover | 6.66 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Leap Therapeutics (NASDAQ:LPTX) through any online brokerage.
Other companies in Leap Therapeutics’s space includes: Serina Therapeutics (AMEX:SER), Anixa Biosciences (NASDAQ:ANIX), Cellectar Biosciences (NASDAQ:CLRB), T2 Biosystems (NASDAQ:TTOO) and MAIA Biotechnology (AMEX:MAIA).
There is no analysis for Leap Therapeutics.
Leap Therapeutics has a consensus price target of $10.40.
The stock price for Leap Therapeutics (NASDAQ: LPTX) is $2.24 last updated July 23, 2024 at 4:33 PM EDT.
There are no upcoming dividends for Leap Therapeutics.
Leap Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Leap Therapeutics.
Leap Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.